TAFINLAR

DABRAFENIB · Novartis Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

61 regulatory and trial events tracked for TAFINLAR, covering 2013-05-29 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer Which Has Spread [Phase 2]